Health · 1 views
Immune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus
Preliminary results from an investigator-initiated, single-site clinical study show that some people with chronic cutaneous lupus erythematosus—a type of lupus that can cause permanent skin damage and hair loss—are less likely to acquire…
Story Brief
Published in the Journal of the European Academy of Dermatology and Venereology ( JEADV ), the findings of the Johns Hopkins Medicine-led study highlight how anifrolumab can provide distinct benefits over conventional immunosuppressants in patients with treatment-resistant chronic skin lupus.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- New disease gene discovery provides answers to familiesContinue reading
- The pediatricians who take in vaccine-skeptical parents others won’tContinue reading
- Family cancer burden predicts risk in patients with inflammatory bowel diseaseContinue reading
- The September reset is real. I’m about to become a better person, flaxseed by flaxseed | Emma BrockesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow